Syncom Formulations (India) Limited (BOM:524470)
India flag India · Delayed Price · Currency is INR
12.21
+0.45 (3.83%)
At close: Jan 22, 2026

Syncom Formulations (India) Company Description

Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India and internationally.

It operates through Manufacturing and Dealing in Pharmaceutical Drug and Formulations, Trading of Commodities, and Renting of Properties segments.

The company offers antibiotics/antiinfectives, anthelmintics, antimalarial, cardiac, derma, gastro, dry syrups and suspensions, creams, gel, ORS, jelly, gynae, inhalers, opthal, ortho, and pediatrics formulations in dosage forms.

It also provides life care, evolve, and the right nutrition products under the Cratus brand. In addition, the company offers its pharmaceutical formulation products in various dosage forms, such as tablets, capsules, ointments, injections, liquids orals, and effervescent.

Syncom Formulations (India) Limited was incorporated in 1988 and is based in Indore, India.

Syncom Formulations (India) Limited
CountryIndia
Founded1988
IndustryPharmaceutical Preparations
Employees744
CEOVijay Bankda

Contact Details

Address:
Syncom House
Indore, 452018
India
Phone91 73 1270 0458
Websitesyncomformulations.com

Stock Details

Ticker Symbol524470
ExchangeBombay Stock Exchange
Fiscal YearApril - March
Reporting CurrencyINR
SIC Code2834

Key Executives

NamePosition
Vijay BankdaChief Executive Officer
Rahul BankdaChief Financial Officer